Functionality of a novel follitropin alfa pen injector: results from human factor interactions by patients and nurses

Abstract

The study provides valuable information on the pen from both patient and nurse perspectives in different simulated scenarios reflecting standard practice.

An evaluation of the use and handling errors of currently available recombinant human follicle-stimulating hormone pen injectors by women with infertility and fertility nurses

“…Another study, looking at the human factor interactions by patients and nurses for the Bemfola pen injector, used a list of pre-defined critical steps according to the IFU to assess the correct handling of the pen injector [20]. Interestingly, no critical errors related to the use of the pen injector were reported in this study and only minor issues were reported related to the priming of the pen injector.…”

Clinical Efficacy of Follitropin Alfa in GnRH-Antagonist Protocols: A Prospective Observational Phase IV Study on the Use of Biosimilar Follitropin Alfa r-hFSH in Assisted Reproductive Technology in a Routine Care Setting

“…Studies showed that it has similar pharmacokinetics, efficacy and safety to the originator product (Gonalf ® , Merck Serono) ( 1 , 2 ). It is available as a prefilled single-use pen which provides a simple to-use alternative to other pens ( 4 – 6 ).…”

“…The complexity of ovarian stimulation regimens can lead to patient non-compliance ( 3 ), and easy-to-use devices could potentially help improve compliance with treatment. The Bemfola ® pen scored well in user acceptance studies ( 4 – 6 ).…”